About this trial
Invasive filamentous fungal infections (aspergillosis, scedosporiosis, mucormycosis, fusarium wilt) are common and serious in immunocompromised subjects and particularly organ transplant patients. There is little recent data in heart transplantation, particularly on the incidence and risk factors of fungal infections. . It is therefore important to have recent data on incidence, risk and prognostic factors in order to improve the management of this severe complication.
Eligibility criteria
Qualifiers
Adult patient ≥18 years old
Heart transplant
Invasive fungal infection with filamentous fungi during the period from January 1, 2008 to December 31, 2022
Invasive aspergillosis
Disqualifiers
Patient having expressed his opposition to participating in the study
Patient not having a liver transplant
Subject under guardianship, curatorship or safeguard of justice.
Trial design
Treatments tested in this trial
- Not listed